Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTUITIVE SURGICAL INC Director's Dealing 2020

Feb 19, 2020

29809_dirs_2020-02-19_0e218c86-67ba-4ec1-b521-25b91677bc34.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2020-02-15

Reporting Person: Andersen Reiter Kara (Sr VP General Counsel & CCO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-15 Common Stock M 438 $0.0 Acquired 3260 Direct
2020-02-15 Common Stock F 183 $0.0 Disposed 3077 Direct
2020-02-15 Common Stock M 657 $0.0 Acquired 3734 Direct
2020-02-15 Common Stock F 326 $0.0 Disposed 3408 Direct
2020-02-15 Common Stock M 675 $0.0 Acquired 4083 Direct
2020-02-15 Common Stock F 234 $0.0 Disposed 3849 Direct
2020-02-16 Common Stock M 750 $0.0 Acquired 4599 Direct
2020-02-16 Common Stock F 268 $0.0 Disposed 4331 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-16 Restricted Stock Units $0.0 M 750 Disposed 2020-02-16 Common Stock (750) Direct
2020-02-15 Restricted Stock Units $0.0 M 675 Disposed 2021-02-15 Common Stock (675) Direct
2020-02-15 Restricted Stock Units $0.0 M 438 Disposed 2022-02-15 Common Stock (438) Direct
2020-02-15 Restricted Stock Units $0.0 M 657 Disposed 2029-02-15 Common Stock (657) Direct

Footnotes

F1: RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

F2: Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.